Chiron Real Estate pairs notable insider buying ($625K, 0.114% of market cap) and elite FCF-backed quality (Rule of 40 of 74) with a bullish golden-cross breakout and a cheap 7.4x P/OCF multiple, though the stock already trades past its analyst target.
Thesis pillars
- Notable Insider Buying Bullish Signal→Stable
- Elite Rule Of 40 Fcf Positive→Stable
- Golden Cross Breakout Setup→Stable
- +2 more pillars — see the Why tab for full reasoning
Pillars as of Jul 5, 2026, based on the 10-K filed Mar 2, 2026
Chiron Real Estate Inc. (XRN) Stock Analysis
Oversold Bounce setup · Sector Rotation edge
Real Estate · REIT - Healthcare Facilities
Sell if holding. Momentum 2.8/10 is below the 5.0 floor at $28.77 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Property Type: Medical Office Building (MOB) (71.9%); Sector modifier (Real Estate): -1.2.
Chiron Real Estate (formerly Global Medical REIT) is an internally managed REIT that owns 189 healthcare facilities totaling 5.1 million square feet, leased primarily to physician groups and regional or national healthcare systems under triple-net leases. Medical office... Read more
Sell if holding. Momentum 2.8/10 is below the 5.0 floor at $28.77 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Property Type: Medical Office Building (MOB) (71.9%); Sector modifier (Real Estate): -1.2. Chart setup: Oversold RSI 21, near Bollinger lower, volume surge. Score 6.0/10, moderate confidence.
Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and earnings proximity 6d<=7d. Suitability: aggressive.
About Chiron Real Estate Inc.
About Chiron Real Estate Inc.
Chiron Real Estate's 189-building healthcare portfolio, spanning approximately 5.1 million square feet of leasable space, generates $118.8 million in annualized base rent, with medical office buildings accounting for 71.9% of that rent. Texas is the company's single largest state exposure at 17.0% of annualized base rent, part of a broader concentration the REIT discloses across Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.
Most of Chiron's healthcare facilities are leased to a single tenant under triple-net leases, meaning tenants bear property-level operating costs and the REIT collects contracted base rent; a smaller share of multi-tenant properties operate under gross or modified gross lease structures. Tenants named LifePoint Health, Encompass Health Corporation, and Memorial Health System each account for at least 5% of annualized base rent, together representing 18.1% of the total. The company's lease maturity ladder is staggered, with only 7.4% of annualized base rent expiring in 2026 and the largest single-year rollovers concentrated in 2029 (15.8%) and 2027 (13.7%). Chiron also holds a 12.5% stake in a joint venture with Heitman, a real estate investment firm with more than $48 billion in assets under management, through which it earns fees for sourcing and managing two healthcare assets, and 12 of its buildings sit on ground leases covering 13.2% of total leasable square feet.
Show full overview
Chiron's own risk factors flag a structural vulnerability distinct from simple revenue-share math: because most of its healthcare facilities are occupied by a single tenant, the REIT says it may have difficulty finding suitable replacement tenants if a tenant defaults or fails to renew, especially for facilities in smaller markets where alternative healthcare operators may be scarce. That single-tenant-per-property design means the loss of even one mid-sized lease can leave an entire building vacant rather than partially vacant, a different risk profile than a multi-tenant office or retail REIT would face from the same dollar amount of lease expiration.
See also: Real Estate · REIT - Healthcare Facilities
From Chiron Real Estate Inc.'s most recent 10-K filing, extracted July 6, 2026.
Recent developments
updated 2026-10-29Recent Developments — Chiron Real Estate Inc.
Latest news
- NEWS Chiron Real Estate names Charles Fitzgerald as board chairman - Investing.com — Investing.com neutral
- NEWS Chiron Real Estate Appoints Charles Fitzgerald as Board Chair - marketscreener.com — marketscreener.com neutral
- NEWS Chiron Real Estate Appoints Charles Fitzgerald as Board Chair - Yahoo Finance — Yahoo Finance neutral
- NEWS Chiron Real Estate Appoints Charles P. Fitzgerald Chairman of the Board - www.marketscreener.com — www.marketscreener.com neutral
- NEWS Chiron Real Estate Inc. Announces Board Changes - www.marketscreener.com — www.marketscreener.com neutral
Generated 2026-10-29T11:53:52Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHPropertyMedical Office Building (MOB)72%10-K Item 1: 'Medical Office Building (MOB) (2)| | 4,035,663| | 79.1| % | $| 85,397| | 71.9| %'
- MEDIUMGeographicTexas, Florida, Ohio, Arizona, Pennsylvania, and Illinois10-K Item 1: 'We have significant geographic concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois. Economic and other conditions that negatively affect those states and our tenants in those states could have a greater effect on our revenues than if our properties were more geographically diverse'
- MEDIUMTenantsignificant tenants (≥5% of ABR)10-K Item 1: 'The following tenants each account for at least 5% of our annualized base rent as of December 31, 2025.'
Material Events(8-K, last 90d)
- 2026-05-20Item 5.02LOWBoard expanded from six to seven members and appointed Charles Fitzgerald, Founder of Maewyn Capital Partners, as a director effective May 20, 2026, serving on the Compensation and Nominating and Corporate Governance Committees. Routine board addition, no departure.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 2.8/10 is below the 5.0 floor at $28.77 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Concentration risk — Property Type: Medical Office Building (MOB) (71.9%); Sector modifier (Real Estate): -1.2. Chart setup: Oversold RSI 21, near Bollinger lower, volume surge. Prior stop was $27.25. Score 6.0/10, moderate confidence.
Analyst target: $37.52 (+30.4% upside). Prior stop was $27.25. Stop-loss: $27.25.
Concentration risk — Property Type: Medical Office Building (MOB) (71.9%); Sector modifier (Real Estate): -1.2; Earnings in 6 days (event risk).
Chiron Real Estate Inc. trades at a P/E of 7.7 (forward -9.0). TrendMatrix value score: 8.3/10. Verdict: Sell.
15 analysts cover XRN with a consensus score of 3.7/5. Average price target: $43.
What does Chiron Real Estate Inc. do?Chiron Real Estate (formerly Global Medical REIT) is an internally managed REIT that owns 189 healthcare facilities...
Chiron Real Estate (formerly Global Medical REIT) is an internally managed REIT that owns 189 healthcare facilities totaling 5.1 million square feet, leased primarily to physician groups and regional or national healthcare systems under triple-net leases. Medical office buildings make up 71.9% of the portfolio's $118.8 million in annualized base rent, and the company reported significant geographic concentration in Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois as of December 31, 2025.